127 related articles for article (PubMed ID: 7849249)
1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
Zhang PL; Jiménez W; Mackenzie HS; Guo J; Troy JL; Ros J; Angeli P; Arroyo V; Brenner BM
J Am Soc Nephrol; 1994 Oct; 5(4):1099-105. PubMed ID: 7849249
[TBL] [Abstract][Full Text] [Related]
2. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
4. Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats.
Zhang PL; Mackenzie HS; Troy JL; Brenner BM
J Am Soc Nephrol; 1994 Feb; 4(8):1564-70. PubMed ID: 8025230
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
Sano T; Morishita Y; Matsuda Y; Yamada K
J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
[TBL] [Abstract][Full Text] [Related]
7. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
8. Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor.
Stevens TL; Wei CM; Aahrus LL; Heublein DM; Kinoshita M; Matsuda Y; Burnett JC
Hypertension; 1994 May; 23(5):613-8. PubMed ID: 8175170
[TBL] [Abstract][Full Text] [Related]
9. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors.
Imura R; Sano T; Goto J; Yamada K; Matsuda Y
Mol Pharmacol; 1992 Dec; 42(6):982-90. PubMed ID: 1362244
[TBL] [Abstract][Full Text] [Related]
11. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
[TBL] [Abstract][Full Text] [Related]
12. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
[TBL] [Abstract][Full Text] [Related]
14. Effects of natriuretic peptide receptor inhibition on remnant kidney function in rats.
Zhang PL; Mackenzie HS; Troy JL; Brenner BM
Kidney Int; 1994 Aug; 46(2):414-20. PubMed ID: 7967353
[TBL] [Abstract][Full Text] [Related]
15. Renal function in high-output heart failure in rats: role of endogenous natriuretic peptides.
Willenbrock R; Pagel I; Scheuermann M; Höhnel K; Mackenzie HS; Brenner BM; Dietz R
J Am Soc Nephrol; 1999 Mar; 10(3):572-80. PubMed ID: 10073608
[TBL] [Abstract][Full Text] [Related]
16. Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.
Kirk JE; Wilkins MR
Br J Pharmacol; 1993 Sep; 110(1):350-4. PubMed ID: 8220896
[TBL] [Abstract][Full Text] [Related]
17. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
[TBL] [Abstract][Full Text] [Related]
18. HS-142-1, a novel non-peptide ANP antagonist, blocks the cyclic GMP production elicited by natriuretic peptides in PC12 and NG108-15 cells.
Toki S; Morishita Y; Sano T; Matsuda Y
Neurosci Lett; 1992 Jan; 135(1):117-20. PubMed ID: 1311820
[TBL] [Abstract][Full Text] [Related]
19. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
20. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.
Sakamoto K; Kikkawa R; Haneda M; Shigeta Y
Diabetologia; 1995 May; 38(5):536-42. PubMed ID: 7489835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]